LIVN - LivaNova takeout at $90/share would be attractive analyst says

A LivaNova (LIVN) buyout at $90/share may be an attractive outcome, Piper Sandler writes after FT report yesterday that PE firm Permira bid more than $80/share last month for the company.Initially, Piper Sandler analyst Adam Maeder wrote that any takeout offer below $90 would likely not result in a deal, though he added that $90 would be attractive if the sides were negotiating using LivaNova's 30-day avg. close pricing of $69.75."We view the combination of a turnaround in the core business and an intriguing pipeline with shots on goal in three massive market opportunities (depression, heart failure, and obstructive sleep apnea) as a solid blueprint for value creation," Maeder writes.He said the Permira bid likely sets up a floor for the stock around $80/share.Separately, Betaville is speculating that talk is LivaNova may get $84-$85share unless a rival bidder emerges.LIVN gained 1.2% in premarket trading.Recall Dec. 3, LivaNova to divest heart valve business to

For further details see:

LivaNova takeout at $90/share would be attractive, analyst says